Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)

April 23, 2026 updated by: Sara Heinert, PhD, MPH, Rutgers, The State University of New Jersey
The pilot study of Project BADGE will focus on emergency department (ED) patients with diabetes, which has significant disparities in prevalence and mortality for underserved populations. The objective is to determine the effect of a text-based resource referral platform with diabetes educational materials on patient diabetes knowledge, diabetes distress, diabetes self-care activities, and acceptability and feasibility of the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New Jersey
      • New Brunswick, New Jersey, United States, 08901
        • Robert Wood Johnson University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adult (18+) ED/observation unit patients
  2. Have poorly controlled or new onset diabetes (hyperglycemia or Diabetic ketoacidosis (DKA))
  3. Speak English or Spanish
  4. Has a cell phone able to send and receive text messages

Exclusion Criteria:

1) Intubated patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Text-based platform
Text-based resource referral platform with diabetes educational materials
Behavioral: Text-based resource referral platform with diabetes educational materials
Text-based resource referral platform with diabetes educational materials

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Doctor Visit
Time Frame: 3 months
Did the patient attend a doctor appointment?
3 months
Diabetes Distress
Time Frame: Baseline, 3 months
2-item Diabetes Distress Scale (DDS2)- if positive on DDS2, will complete DDS17 (On a scale of 1- "not a problem" to 6- "a very serious problem.")
Baseline, 3 months
Diabetes Knowledge
Time Frame: Baseline, 3 months
Diabetes Knowledge Questionnaire, with response choices of Yes, No, or I Don't Know
Baseline, 3 months
Diabetes Self-Care
Time Frame: Baseline, 3 months
Diabetes Self-Care Assessment, which asks about ask you about diabetes self-care activities during the past 7 days.
Baseline, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Acceptability
Time Frame: 3 months
Acceptability of Intervention Measure (AIM) on a scale of 1 (completely disagree) to 5 (completely agree)
3 months
Intervention Feasibility
Time Frame: 3 months
Feasibility of Intervention Measure (FIM) on a scale of 1 (completely disagree) to 5 (completely agree)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rutgers, The State University of New Jersey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2025

Primary Completion (Actual)

March 3, 2026

Study Completion (Actual)

March 24, 2026

Study Registration Dates

First Submitted

December 13, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

December 16, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro2024001476

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe